Long-Term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies

CONTEXT: A minimally toxic nonmyeloablative regimen was developed for allogeneic hematopoietic cell transplantation (HCT) to treat patients with advanced hematologic malignancies who are older or have comorbidities. OBJECTIVE: To describe outcomes of patients ≥ 60 years. DESIGN, SETTING, AND PARTICI...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sorror, Mohamed L., Sandmaier, Brenda M., Storer, Barry E., Franke, Georg N., Laport, Ginna G., Chauncey, Thomas R., Agura, Edward, Maziarz, Richard T., Langston, Amelia, Hari, Parameswaran, Pulsipher, Michael A., Bethge, Wolfgang, Sahebi, Firoozeh, Bruno, Benedetto, Maris, Michael B., Yeager, Andrew, Petersen, Finn Bo, Vindeløv, Lars, McSweeney, Peter A., Hübel, Kai, Mielcarek, Marco, Georges, George E., Niederwieser, Dietger, Blume, Karl G., Maloney, David G., Storb, Rainer
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3217787/
https://ncbi.nlm.nih.gov/pubmed/22045765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2011.1558
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi